Biocompatible Microemulsion Modifies the Pharmacokinetic Profile and Cardiotoxicity of Doxorubicin-Reference-Cited by-同舟云学术

Biocompatible Microemulsion Modifies the Pharmacokinetic Profile and Cardiotoxicity of Doxorubicin

Published:2013-01 Issue:1 Volume:102 Page:289-296
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

AssumpçãO Juliana Uruguay Correa Vidigal,Campos Michel Leandro,Ferraz Nogueira Filho Marco Antonio,Pestana Kelly Chrystina,Baldan Helen Mariana,Formariz Pilon Thalita Pedroni,de Oliveira Anselmoc Gomes,Peccinini Rosângela Gonçalves

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference23 articles.

1. Relationship between structural features and in vitro release of doxorubicin from biocompatible anionic microemulsion;Formariz;Colloid Surf B Biointerfaces,2007

2. Cell involved in the capture of nanoparticles in hematopoietic organs;Gibaud;J Pharm Sci,1996

3. Doxorubicin‐induced cardiomyopathy: From molecular mechanisms to therapeutic strategies;Octavia;J Mol Cell Cardiol,2012

4. Doxorubicin and mechanical performance of cardiac trabeculae after acute chronic treatment: A review;Beer;Eur J Pharmacol,2001

5. Alterations in P‐glycoprotein expression in mouse tissues by doxorubicin: Implications for pharmacokinetics in multiple dosing regimens;Gustafson;Chem Biol Interact,2001

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parenteral microemulsions for drug delivery: Advances and update;Journal of Drug Delivery Science and Technology;2023-11

2. A review on various analytical methods for determination of anthracyclines and their metabolites as anti–cancer chemotherapy drugs in different matrices over the last four decades;TrAC Trends in Analytical Chemistry;2020-09

3. Formulation, drug release features and in vitro cytotoxic evaluation of nonionic mixed surfactant stabilized water-in-oil microemulsion loaded with doxorubicin;Mendeleev Communications;2019-05

4. Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer;Biomaterials;2019-02

5. cAMP-PKA-CaMKII signaling pathway is involved in aggravated cardiotoxicity during Fuzi and Beimu Combination Treatment of Experimental Pulmonary Hypertension;Scientific Reports;2016-10-14